Alps Advisors Inc Agios Pharmaceuticals, Inc. Transaction History
Alps Advisors Inc
- $14.1 Billion
- Q1 2024
A detailed history of Alps Advisors Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 39,640 shares of AGIO stock, worth $1.63 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
39,640
Previous 37,844
4.75%
Holding current value
$1.63 Million
Previous $842,000
37.65%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding AGIO
# of Institutions
207Shares Held
60MCall Options Held
365KPut Options Held
457K-
Farallon Capital Management LLC San Francisco, CA5.59MShares$230 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$230 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$192 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.01MShares$165 Million1.84% of portfolio
-
State Street Corp Boston, MA3.14MShares$129 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.26B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...